# Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

> **NCT00033722** · PHASE2 · UNKNOWN · sponsor: **Tularik**

## Conditions studied

- Lung Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** folic acid
- **DRUG:** lometrexol

## Key facts

- **NCT ID:** NCT00033722
- **Lead sponsor:** Tularik
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033722, "Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00033722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*